Thermo Fisher Scientific Inc (NYSE:TMO) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, July 26th. Analysts expect Thermo Fisher Scientific to post earnings of $2.26 per share for the quarter. Thermo Fisher Scientific has set its FY17 guidance at $9.12-9.28 EPS.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, April 26th. The medical research company reported $2.08 EPS for the quarter, topping the Zacks’ consensus estimate of $2.02 by $0.06. Thermo Fisher Scientific had a return on equity of 15.73% and a net margin of 11.58%. The firm had revenue of $4.77 billion for the quarter, compared to the consensus estimate of $4.68 billion. During the same quarter last year, the business posted $1.80 earnings per share. The firm’s revenue was up 10.9% compared to the same quarter last year. On average, analysts expect Thermo Fisher Scientific to post $9.23 EPS for the current fiscal year and $10.18 EPS for the next fiscal year.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 179.35 on Wednesday. The company’s 50-day moving average price is $173.88 and its 200-day moving average price is $158.53. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $181.27. The stock has a market cap of $70.17 billion, a P/E ratio of 32.72 and a beta of 1.06.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.33%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is 10.95%.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the completion of the transaction, the chief executive officer now owns 269,279 shares of the company’s stock, valued at $46,528,718.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas W. Loewald sold 1,532 shares of the firm’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $168.76, for a total value of $258,540.32. Following the transaction, the insider now directly owns 41,277 shares of the company’s stock, valued at approximately $6,965,906.52. The disclosure for this sale can be found here. Insiders have sold 28,720 shares of company stock valued at $4,960,764 in the last three months. Insiders own 0.49% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This report was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/07/19/thermo-fisher-scientific-inc-tmo-scheduled-to-post-earnings-on-wednesday.html.

TMO has been the subject of a number of research analyst reports. Morgan Stanley raised their price target on Thermo Fisher Scientific from $186.00 to $192.00 and gave the stock an “overweight” rating in a research note on Friday, April 28th. Barclays PLC reaffirmed an “overweight” rating and issued a $190.00 price target (up previously from $175.00) on shares of Thermo Fisher Scientific in a research note on Tuesday, May 9th. Deutsche Bank AG raised their price target on Thermo Fisher Scientific from $163.00 to $188.00 and gave the stock a “buy” rating in a research note on Friday, April 28th. Leerink Swann set a $187.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, April 27th. Finally, Cowen and Company reaffirmed an “outperform” rating and issued a $185.00 price target (up previously from $175.00) on shares of Thermo Fisher Scientific in a research note on Saturday, April 29th. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the stock. Thermo Fisher Scientific has a consensus rating of “Buy” and a consensus target price of $187.29.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Earnings History for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.